August 22, 2016
Advised Medivation on its ~$14 billion sale to Pfizer Inc.
May 19, 2016
Advising FMC Technologies, Inc. on its ~$6.1 billion merger of equals with Technip SA LLC.
April 28, 2016
Advising Abbott Laboratories on its ~$31 billion acquisition of St. Jude Medical, Inc.
April 27, 2016
Advising the Special Committee of the Board of Facebook, Inc. on its proposed multi-class recapitalization.
April 18, 2016
Advised MGM Growth Properties on its $1.2 billion IPO – the third largest REIT IPO in history.
In the News
October 6, 2016
Evercore ISI named # 3 in U.S. Equity Research by Institutional Investor’s All-America Equity Research Survey
NEW YORK, October 6, 2016 – Evercore ISI was named #3 in Institutional Investor’s All-America Equity Research survey, with 30 ranked analysts in total. This marks the third year in a row that Evercore ISI has placed in the top 5 firms in the annual survey. On a weighted basis (i.e. higher weighting assigned to a #1 rank and lower weighting assigned for a runner-up rank) Evercore ISI ranked #2 to J.P. Morgan.more >
September 12, 2016
Dimitrios Georgiou Joins Evercore as Senior Managing Director in the Industrials Corporate Advisory Practice in London
LONDON, September 12, 2016 – Evercore (NYSE:EVR) announced today that Dimitrios Georgiou has joined the Firm’s Investment Banking business as a Senior Managing Director. Mr. Georgiou will be based in London and will focus on advising clients on M&A and capital-raising assignments in the Industrials and Services sectors.more >